Work

From Acute Infectious Myocarditis to Chronic Inflammatory Cardiomyopathy: Pathophysiological Mechanisms, Key Investigations, and Current Treatment Strategies

Year: 2026
Type: article
Abstract: Acute infectious myocarditis is an inflammatory disease of the myocardium caused by a broad range of infectious agents, including viruses, bacteria, fungi, protozoa, helminths, and spirochetes. Its clinical presentation is highly variable, ranging from asymptomatic or mild self-limiting disease to fulminant heart failure, life-threatening arrhythmias, cardiogenic shock, and sudden cardiac death. Although many patients recover completely, persistent myocardial inflammation, incomplete pathogen clearance, immune-mediated injury, and myocardial fibrosis may lead to adverse ventricular remodelling, persistent ventricular dysfunction, and progression to chronic inflammatory cardiomyopathy or dilated cardiomyopathy. The pathophysiology reflects a complex interaction between direct pathogen-mediated myocardial injury and innate and adaptive immune responses, with the balance between effective pathogen clearance and excessive inflammation being a major determinant of outcome. Diagnosis remains challenging because clinical manifestations and conventional investigations are often nonspecific. A multimodal approach incorporating electrocardiography, cardiac biomarkers, echocardiography, cardiovascular magnetic resonance (CMR), microbiological and molecular investigations, and, in selected patients, endomyocardial biopsy is essential for diagnosis and risk stratification. CMR is particularly valuable for identifying myocardial edema, inflammation, necrosis, and fibrosis, whereas endomyocardial biopsy remains important in selected severe or diagnostically uncertain cases. Treatment is primarily guided by clinical severity and the identified infectious etiology. Management includes supportive heart failure therapy, arrhythmia control, temporary restriction of physical activity, and mechanical circulatory support in severe or fulminant disease. Targeted antimicrobial therapy is essential when a treatable pathogen is identified, while routine empiric antiviral therapy or immunosuppression is not currently supported for most presumed viral myocarditis. Emerging approaches involving molecular diagnostics, immunological profiling, novel biomarkers, targeted modulation of inflammatory pathways, and personalized therapies may improve diagnosis and outcomes. This review summarizes current evidence on the etiology, pathophysiology, clinical presentation, diagnosis, treatment, and progression from infectious myocarditis to chronic inflammatory cardiomyopathy.
Source: Pathogens
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,654
OpenAlex ID: W7236863031
FWCI:
Cites: 197
Cited by:
Related to: 10